Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China
Search for other papers by Xun Wang in
Google Scholar
PubMed
Search for other papers by Aiqi Zhang in
Google Scholar
PubMed
Search for other papers by Wenchao Yao in
Google Scholar
PubMed
Search for other papers by Haiyan Qiu in
Google Scholar
PubMed
Search for other papers by Fabo Feng in
Google Scholar
PubMed
patients with long-term follow-up 251 Wong et al. ( 52 ) 2008 Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2) 242 Parker et al
Search for other papers by Bart G. Pijls in
Google Scholar
PubMed
Search for other papers by Jennifer M. T. A. Meessen in
Google Scholar
PubMed
Search for other papers by Keith Tucker in
Google Scholar
PubMed
Search for other papers by Susanna Stea in
Google Scholar
PubMed
Search for other papers by Liza Steenbergen in
Google Scholar
PubMed
Search for other papers by Anne Marie Fenstad in
Google Scholar
PubMed
Search for other papers by Keijo Mäkelä in
Google Scholar
PubMed
Search for other papers by Ioan Cristian Stoica in
Google Scholar
PubMed
Search for other papers by Maxim Goncharov in
Google Scholar
PubMed
Search for other papers by Søren Overgaard in
Google Scholar
PubMed
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
Instituto de Biomedicina (IBIOMED). Universidad de León, León, Spain
Search for other papers by Jorge Arias de la Torre in
Google Scholar
PubMed
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Search for other papers by Anne Lübbeke in
Google Scholar
PubMed
Search for other papers by Ola Rolfson in
Google Scholar
PubMed
Search for other papers by Rob G. H. H. Nelissen in
Google Scholar
PubMed
expect surgeons to use all components of the same manufacturer, almost all included registries report off-label mix-and-match prostheses, except for the GAR. The NAR and RAR reported that these mix-and-match prostheses consist of the use of BHR acetabular
Bucharest Emergency Clinical Hospital, Romania
Search for other papers by Razvan Ene in
Google Scholar
PubMed
University Emergency Hospital Bucharest, Romania
Search for other papers by Mihai Nica in
Google Scholar
PubMed
Bucharest Emergency Clinical Hospital, Romania
Search for other papers by Dragos Ene in
Google Scholar
PubMed
University Emergency Hospital Bucharest, Romania
Search for other papers by Adrian Cursaru in
Google Scholar
PubMed
University Emergency Hospital Bucharest, Romania
Search for other papers by Catalin Cirstoiu in
Google Scholar
PubMed
antibiotic delivery system based on bioactive glass. Until solid data are provided by research into this synthetic biomaterial as an antibiotic delivery system its use for this purpose remains experimental and off-label. 31 – 34 Calcium phosphate
Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
Search for other papers by Marcel Niemann in
Google Scholar
PubMed
Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
Search for other papers by Ellen Otto in
Google Scholar
PubMed
Search for other papers by Christian Eder in
Google Scholar
PubMed
Search for other papers by Yasmin Youssef in
Google Scholar
PubMed
Search for other papers by Lutz Kaufner in
Google Scholar
PubMed
Search for other papers by Sven Märdian in
Google Scholar
PubMed
( 1 ) We do not recommend the use of recombinant- activated coagulation factor VII ( rFVIIa ) as first-line treatment . We suggest that the off-label use of rFVIIa be considered only if major bleeding and traumatic coagulopathy persist despite
Search for other papers by Pelle V Wall in
Google Scholar
PubMed
Search for other papers by Brendon C Mitchell in
Google Scholar
PubMed
Search for other papers by Canhnghi N Ta in
Google Scholar
PubMed
Search for other papers by William T Kent in
Google Scholar
PubMed
, and risk of thrombosis may complicate their use. Further, these reversal agents are not approved for all DOACs ( 48 ). Prothrombin complex concentrate (PCC) and activated prothrombin complex concentrate (APCC) have also been used off-label for DOAC
Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK
Search for other papers by Marilena Giannoudi in
Google Scholar
PubMed
NIHR Leeds Biomedical Research Centre, Chapel Allerton Hospital, Leeds, UK
Search for other papers by Peter V Giannoudis in
Google Scholar
PubMed
, there have been no studies directly comparing the use of DOAC antidotes to PCC and APCC ( 55 ). Such agents have therefore been typically used in an off-label fashion prior to the invention of the direct antidotes and currently when such antidotes are
Search for other papers by Paul L Rodham in
Google Scholar
PubMed
Search for other papers by Vasileios P Giannoudis in
Google Scholar
PubMed
Department of Trauma & Orthopaedics, University of Leeds, Leeds, United Kingdom of Great Britain and Northern Ireland
Search for other papers by Nikolaos K Kanakaris in
Google Scholar
PubMed
Search for other papers by Peter V Giannoudis in
Google Scholar
PubMed
off-label, BMPs have also been investigated in the management of critical bone defects. In a canine ulna model, Salkeld et al. were able to demonstrate that the combination of Rh-BMP 7 with either autograft or allograft lead to faster times to union
Search for other papers by Victor Lu in
Google Scholar
PubMed
Search for other papers by Maria Tennyson in
Google Scholar
PubMed
Search for other papers by Andrew Zhou in
Google Scholar
PubMed
Search for other papers by Ravi Patel in
Google Scholar
PubMed
Search for other papers by Mary D Fortune in
Google Scholar
PubMed
Search for other papers by Azeem Thahir in
Google Scholar
PubMed
Search for other papers by Matija Krkovic in
Google Scholar
PubMed
( 45 ). A higher proportion of ankles treated with a non-ankle fusion nail used ‘off-label’ have implant failure than those that used nails specific for hindfoot stabilisation. Furthermore, short nails that do not cross the tibial isthmus were assumed